|
¸ñÂ÷
01 Gastroenterology ¥°. Upper GI disease 1. Esophageal motility disorder 2. GERD (Gastroesophageal reflux disease) 3. Various esophagitis 4. Gastropathy and gastritis 5. Helicobacter pylori 6. Peptic ulcer disease (PUD) 7. NSAID induced gastrointestinal damage 8. Gastric polyps 9. À§¼±Á¾°ú Á¶±âÀ§¾ÏÀÇ ³»½Ã°æ Ä¡·á 10. Gastrointestinal bleeding
¥±. Lower GI disease 1. ConstipationÀÇ Áø´Ü°ú Ä¡·á 2. Diarrhea 3. Ischemic diseases of the bowel 4. Infectious gastroenteritis 5. Inflammatory bowel diseases 6. Intestinal tuberculosis (´ëÇѼÒȱâÇÐȸ °¡À̵å¶óÀÎ Âü°í) 7. Colonic diverticula 8. Intestinal obstruction 9. Colon polyp (´ëÀå ¿ëÁ¾) 10. Functional Dyspepsia 11. Irritable Bowel Syndrome
02 Hepatobiliary disease 1. Liver function testÀÇ ÇØ¼® 2. Acute hepatitis A 3. Chronic Hepatitis B 4. Chronic Hepatitis C 5. Autoimmune hepatitis 6. Alcoholic hepatitis 7. Ischemic hepatitis (shock liver) 8. Liver abscess (pyogenic, amebic) 9. Acute hepatitis/acute hepatic failure 10. Drug induced liver injury 11. Cirrhosis 12. Gastroesophageal Varices & Variceal Hemorrhage 13. Ascites 14. Spontaneous bacterial peritonitis (SBP) 15. Hepatic encephalopathy 16. Hepatorenal syndrome 17. HCC (hepatocellular carcinoma) 18. Biliary Tract Disease 19. Pancreatitis 20. EUS (Endoscopic ultrasonography) 21. Tumor in pancreas
03 Cardiology 1. Ischemic heart disease 2. Heart Failure 3. ½É±ÙÁúȯ 4. Valvular Heart Disease 4-1. Mitral Stenosis (MS) 4-2. Mitral Regurgitation (MR) 4-3. Aortic Stenosis (AS) 4-4. Aortic Regurgitation (AR) 4-5. Preop. evaluation pathway for VHD in SMC 4-6. ÆÇ¸·Áúȯ ȯÀÚ¿¡¼ÀÇ Ç×ÀÀ°í ¿ä¹ý 5. ½É³¶Áúȯ 6. Arrhythmia 7. Syncope 8. Hypertension 9. Aorta Disease 10. Peripheral artery diseases (PAD) 10-1. Ischemic limb disease 10-2. Extracranial Carotid Stenosis 11. Ç÷°ü¿°(Vasculitis) 11-1. Ÿī¾ß¼ö µ¿¸Æ¿°(Takayasu¡¯s arteritis) 11-2. ¹ö°Å¾¾ º´(Buerger¡¯s disease, TAO; thromboangiitis obliterans) 12. Pulmonary Hypertension (ESC guideline 2015) 13. Perioperative Cardiovascular Evaluation in Noncardiac Surgery 14. BLS (Basic life support) and ACLS (Advanced cardiac life support)
04 Pulmonology 1. È£Èí±â Áõ»óº° Á¢±Ù¹ý 2. È£Èí±â ³»°úÀÇ °Ë»ç ¹æ¹ýµé 3. Pneumonia (Æó·Å) 4. Lung abscess 5. Mycobacterial disease 6. Bronchiectasis 7. Chronic Obstructive Pulmonary Disease (¸¸¼ºÆó¼â¼º ÆóÁúȯ) 8. Interstitial Lung Disease (°£Áú¼º ÆóÁúȯ) 9. Diffuse panbronchiolitis 10. Pulmonary embolism 11. Pleural effusion 12. ±Þ¼ºÈ£ÈíºÎÀü(Acute respiratory failure) 13. ±â°èȯ±âÀÇ ±âÃÊ 14. ARDS ventilator strategies 14-1. Weaning from Mechanical Ventilation 15. Airway Management 16. Management of shock 17. Sepsis
05 Endocrinology 1. DM (Diabetes Mellitus) 2. ³úÇϼöü Áúȯ 3. °©»ó¼± Áúȯ 4. Disorders of adrenal cortex 5. Pheochromocytoma 6. Osteoporosis 7. Disorders of lipoprotein metabolism (Dyslipidemias)
06 Nephrology 1. ¿ä°Ë»çÀÇ ÇØ¼® 2. Urine sediment 3. GFR 4. ´Ü¹é´¢(proteinuria) 5. Ç÷´¢È¯ÀÚ 6. ½Å»ý°Ë(Renal biopsy) 7. Renal imaging 8. »ê¿°±â Àå¾Ö 9. Sodium and Water Homeostasis 10. Hyponatremia 11. Hypernatremia 12. Diabetes insipidus 13. Potassium and calcium homeostasis 14. Phosphate and magnesium 15. Acute Kidney Injury 16. Contrast nephropathy 17. Chronic kidney disease 18. CAPD exit site and tunnel infections (ISPD guidelines 2010) 19. CAPD peritonitis 20. Vascular access for hemodialysis 21. Åõ¼® ÀûÀýµµ(Dialysis adequacy)ÀÇ Æò°¡ 22. Ç÷¾× Åõ¼® ÇÕº´Áõ(Complication during dialysis) 23. ÀÌ´¢Á¦¿Í refractory edema 24. Primary glomerulonephritis 25. Àü½Å Áúȯ°ú ½ÅÀåÁúȯ
07 Hematology-Oncology ¥°. Hematology 1. Thrombocytopenia 2. Immune thrombocytopenic purpura (ITP) 3. TTP (Thrombotic thrombocytopenic purpura) 4. HUS (Hemolytic uremic syndrome) 5. DIC (Disseminated intravascular coagulation) 6. Approach to the adult patient with anemia 7. Iron deficiency anemia (IDA) 8. Anemia of chronic disease (ACD) 9. Megaloblastic anemia 10. Hemolytic anemia 11. Approach to the adult patients with pancytopenia 12. Aplastic Anemia 13. Myelodysplastic syndrome (MDS) 14. Polycythemia vera (PV) 15. Primary myelofibrosis (PMF) 16. Essential thrombocytosis (ET) 17. Chronic Myeloid Leukemia (CML) 18. Granulocyte-colony stimulating factor (G-CSF) and Erythropoietin 19. Transfusion medicine 20. Introduction of Acute leukemia 21. Acute Myelocytic Leukemia (AML) 22. Acute Lymphoid Leukemia (ALL) 23. Hematopoietic stem cell transplantation (HSCT) 24. Multiple Myeloma (MM) 25. Palpable lymph nodes 26. Non-Hodgkin¡¯s lymphoma (NHL) 27. Hodgkin¡¯s Disease ¥±. Oncology 1. Oncology overview 2. Chemotherapy overview 3. Pain control 4. Antiemesis 5. Oncologic Emergencies 6. Head and neck cancer 7. Esophageal cancer 8. Breast cancer 9. Lung Cancer 10. Stomach cancer 11. ¿ÏÈÀÇÇÐ
08 Infection 1. ¹ß¿ ȯÀÚ¿¡ ´ëÇÑ ÀÓ»óÀû Á¢±Ù 2. ¼¼±Õ ¹è¾ç °Ë»ç ¹× °¨¼ö¼º ÇØ¼® 3. ÇǺΠ¿¬Á¶Á÷ °¨¿° 4. °ñ°üÀý °¨¿° 5. ¿ä·Î °¨¿°Áõ(Urinary tract infection, UTI) 6. º¹°³» °¨¿°(Intraabdominal infection) 7. °¨¿°¼º ½É³»¸·¿°(infective endocarditis) 8. Ä«Å×ÅÍ °ü·Ã Ç÷·ù°¨¿°(catheter-related bloodstream infection) 9. ±Þ¼º ³ú¼ö¸·¿°(Acute meningitis) 10. ¹ÙÀÌ·¯½º °¨¿°Áõ 11. Àμö°øÅë°¨¿°Áõ 12. Áø±Õ °¨¿°Áõ 13. Neutropenic fever 14. ¸»¶ó¸®¾Æ °¨¿°Áõ(Malaria) 15. ¼ºÀÎ ¿¹¹æ Á¢Á¾°ú ¿©Çà ÀÇÇÐ(2019³â ´ëÇѰ¨¿°ÇÐȸ ±ÇÀå ¼ºÀο¹¹æÁ¢Á¾Ç¥) 16. Àå±â ÀÌ½Ä È¯ÀÚÀÇ °¨¿°Áõ(Post-transplant infection)
09 Rheumatology 1. Approach to articular and musculoskeletal disorders 2. ·ù¸¶Æ¼½º ÁúȯÀ» À§ÇÑ ÀÓ»óº´¸® °Ë»çÀÇ ÇØ¼® 3. ·ù¸¶Æ¼½º °üÀý¿°(Rheumatoid arthritis) 4. Systemic Lupus Erythematosus(Àü½Å È«¹Ý·çǪ½º) 5. Gout (Monosodium urate gout) 6. Spondyloarthropathies 7. Vasculitis 8. Behcet¡¯s Disease 9. Sjögren¡¯s syndrome 10. Inflammatory Myopathy(¿°Áõ¼º ±Ùº´Áõ) 11. Scleroderma, Systemic sclerosis 12. Adult Onset Still's Disease (AOSD) 13. ¼¶À¯±ÙÅë(Fibromyalgia) 14. Àç¹ß´Ù¹ß¿¬°ñ¿°(Relapsing polychondritis)
10 Allergy 1. Diagnosis of allergic diseases 2. Asthma 3. Allergic rhinitis 4. Chronic cough 5. Adverse drug reactions 6. Anaphylaxis 7. Eosinophilia(È£»ê±¸Áõ°¡Áõ) 8. Urticaria and angioedema 11 Neurology 1. Neurologic examination 2. Coma 3. Stroke 4. Seizure 5. Spinal cord, spinal nerve, and periphral nerve 6. Headache
¼¹®
»ï¼º³»°ú¸Å´º¾óÀº ³»°ú ÁÖÄ¡ÀǷμ ¹Ýµå½Ã ¾Ë¾Æ¾ß ÇÏ´Â ÃֽŠÁø·áÁöħ, °¡À̵å¶óÀÎÀÌ ºüÁü¾øÀÌ ¼ö·ÏµÈ Æ÷ÄÏ ¸Å´º¾ó ÀÌ´Ù.
ù°, º´µ¿°ú ÀÀ±Þ½Ç, ÁßȯÀڽǿ¡¼ ³»°ú ¼ö·ÃÀǵéÀÌ ÈçÇÏ°Ô Á¢ÇÏ´Â ÁúȯÀ» Áß½ÉÀ¸·Î ÀÌ¿¡ ´ëÇÑ ÀÓ»ó Áö½ÄÀÇ ¿ä¾à °ú ÃÖ±Ù º¸°íµÇ°í ÀÖ´Â Ä¡·áÁöħ(guideline)À» ÷ºÎÇÏ¿´´Ù.
µÑ°, È޴뼺ÀÌ ÁÁÀº Å©±â·Î Á¦ÀÛÇÏ¿© ÈÞ´ë°¡ °£ÆíÇÏ´Ù.
¼Â°, ±³°ú¼¿¡¼´Â ½±°Ô ã¾ÆÁöÁö ¾ÊÀ¸³ª ÁÖÄ¡Àǰ¡ ȯÀÚ¸¦ Áø·áÇÒ ¶§ ¾Ë°í ÀÖ¾î¾ß ÇÏ´Â ³»¿ëÀÌ Ç³¼ºÇÏ°Ô ´ã°Ü ÀÖ ´Ù.
ȯÀÚ¸¦ óÀ½ Á¢ÇÏ°Ô µÇ´Â Àǰú´ëÇÐ Çлý, Áø·á Àϼ±¿¡¼ Áø·á¸¦ ¹è¿ì°í ¼öÇàÇÏ´Â Àü°øÀÇ, ¶ÇÇÑ ½ÇÁ¦ óġ¸¦ ´ã´çÇÏ ´Â Áø·áÇöÀåÀÇ ¸ðµç ºÐµé²² ÀÌ Áöħ¼°¡ Å« µµ¿òÀÌ µÇ¸®¶ó È®½ÅÇÑ´Ù.
|